FIELD: medicine.
SUBSTANCE: invention refers to experimental medicine and veterinary science. The invention disclosed unexpected administration of Pro-Gly-Pro peptide as an intranasal agent in prevention and treatment of gastric ulcer in rats.
EFFECT: invention provides higher effectiveness and simplified administration of the agent.
5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTING AND TREATING GASTRIC ULCERS IN ANIMALS | 2002 |
|
RU2217158C1 |
METHOD FOR PREVENTING AND TREATING ULCERS OF GASTRO-INTESTINAL TRACT | 2003 |
|
RU2252779C1 |
AGENT FOR PROPHYLAXIS AND TREATMENT OF GASTROENTERIC TRACT ULCERS, METHOD OF TREATMENT AND METHOD OF PROPHYLAXIS OF GASTROENTERIC TRACT ULCERS | 2001 |
|
RU2191593C1 |
METHOD OF TREATING DIABETES IN ANIMALS | 2009 |
|
RU2403910C1 |
APPLICATION OF Pro-Gly-Pro-Leu TETRAPEPTIDE AS AGENT FOR PREVENTION AND TREATMENT OF DIABETES, METHOD FOR PREVENTION AND TREATMENT OF DIABETES AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF DIABETES | 2008 |
|
RU2378005C1 |
APPLICATION OF Thr-Lys-Pro-Arg-Pro-Gly-Pro PEPTIDE (SELANK) FOR TOXIC HEPATITIS PREVENTION AND TREATMENT | 2017 |
|
RU2640133C1 |
USING TETRAPEPTIDE Pro-Gly-Pro-Val AS AGENT FOR PREVENTING AND TREATING LIPID STORAGE DISEASE, METHOD FOR PREVENTING AND TREATING LIPID STORAGE DISEASE, PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING LIPID STORAGE DISEASE AND METHOD FOR PREPARING IT | 2013 |
|
RU2537133C2 |
APPLICATION OF THR-LYS-PRO-ARG-PRO-GLY-PRO PEPTIDE (SELANK) FOR HEPATOPROTECTIVE IMPACT IN CHRONIC EMOTIONAL-PAIN STRESS | 2016 |
|
RU2629832C1 |
USING TETRAPEPTIDE Arg-Pro-Gly-Pro AS AGENT FOR PREVENTING AND TREATING HYPERCHOLESTEREMIA, METHOD FOR PREVENTING AND TREATING HYPERCHOLESTEREMIA, PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING HYPERCHOLESTEREMIA AND METHOD FOR PREPARING IT | 2013 |
|
RU2538801C2 |
USE OF PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANC) HEPATOPROTECTIVE FOR EXPOSURE IN ACUTE IMMOBILISATION STRESS | 2015 |
|
RU2582963C1 |
Authors
Dates
2011-03-27—Published
2009-12-29—Filed